John Cheneval

John Cheneval has served as the Executive Director, Business Development, since January 2021, leading Castle’s business development opportunities and pharma engagement activities. He has over 31 years of sales, sales management, marketing, corporate accounts, and business development experience in the diagnostics and pharmaceutical sectors, as well as in the licensing of diagnostic assays and intellectual property related to novel genomic tests. Prior to joining Castle, Mr. Cheneval served as Vice President of Pharma Partnerships at HTG Molecular, leading a team of business development professionals. He also spent over 19 years at Ortho-Clinical Diagnostics, a Johnson & Johnson company, and four years at Novartis Molecular Diagnostics.

Mr. Cheneval holds a B.S degree in medical technology from the Louisiana State University School of Allied Health.